Pay in 4 interest-free payments of $24.40 Learn more
Ships within 48 hours · Estimated delivery Sep 16 - Sep 21
6% at 5 μM
The anti-cancer cell activity of deltarasin can be enhanced by simultaneously blocking "tumor protective" autophagy
also known as SN 4521
Smiles: CCN(CCOC1C=CC(=CC=1)C(=C(Cl)C1C=CC=CC=1)C1C=CC=CC=1)CC
20)21/h3-9H
Vatalanib dihydrochloride Catalog No.:M10925-2 6% at 5 μMVatalanib, also known as PTK787, is an orally bioavailable anilinophthalazine with potential antineoplastic activity. Vatalanib binds to and inhibits the protein kinase domain of vascular endothelial growth factor receptors 1 and 2; both receptor tyrosine kinases are involved in angiogenesis. This agent also binds to and inhibits related receptor tyrosine kinases, including platelet derived growth factor (PDGF) receptor, c Kit, and c Fms. Product